tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Ling Wang, 29 are a BUY (100%).
Analyst Ling Wang, currently employed at JPMORGAN, carries an average stock price target met ratio of 46.3% that have a potential upside of 49.19% achieved within 444 days. Previously, Ling Wang worked at BTIG, OPPENHEIMER, CHARDAN CAPITAL.
Ling Wang’s has documented 68 price targets and ratings displayed on 11 stocks. The coverage is on Healthcare, Technology sectors.
Most recent stock forecast was given on DQ, Daqo New Energy Corp ADR at 24-Sep-2021.
Analyst best performing recommendations are on LJPC (LA JOLLA PHARMACEUTICAL CO).
The best stock recommendation documented was for LJPC (LA JOLLA PHARMACEUTICAL CO) at 4/20/2015. The price target of $43 was fulfilled within 141 days with a profit of $23.93 (125.49%) receiving and performance score of 8.9.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 12-Feb-2024
$31
$-0.23 (-0.74%)
$31
2 years 7 months 25 days ago
(12-Feb-2024)
5/6 (83.33%)
$-0.23 (-0.74%)
121
Buy Since 04-Dec-2023
$31
$-0.23 (-0.74%)
$31
2 years 10 months 3 days ago
(04-Dec-2023)
4/4 (100%)
$1.78 (6.09%)
887
Buy Since 04-Mar-2019
$25
$-6.23 (-19.95%)
2 years 10 months 6 days ago
(01-Dec-2023)
2/3 (66.67%)
$-4.32 (-14.73%)
1387
Buy Since 01-Dec-2023
$31
$-0.23 (-0.74%)
2 years 10 months 6 days ago
(01-Dec-2023)
2/2 (100%)
$1.68 (5.73%)
294
Buy Since 16-Nov-2022
$31
$-0.23 (-0.74%)
$26
2 years 10 months 6 days ago
(01-Dec-2023)
4/4 (100%)
$1.68 (5.73%)
114
What Year was the first public recommendation made by Ling Wang?
